We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
188 own
69 watching
Current Price
$374.76
$4.43
(1.2%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
356,256.97M
52-Week High
375.185
52-Week Low
231.87
Average Volume
1.93M
Dividend Yield
0.012415
P/E Ratio
40.4129
Market Capitalization356,256.97M
52-Week High375.185
52-Week Low231.87
Average Volume1.93M
Dividend Yield0.012415
P/E Ratio40.4129
What does the Stockal+Disclaimer.pdf do?
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine headaches. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, and heartworm diseases, as well as controls intestinal parasite infections. Additionally, the company offers vaccinev to prevent Lyme disease, bronchial infections, rabies, and various infectious diseases in dogs, cats, and horses. It has collaboration agreements with Daiichi Sankyo Co., Ltd., Incyte Corporation, Pfizer Inc., AstraZeneca, and William Sansum Diabetes Center. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
3days ago
Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) PR Newswire VANCOUVER, British Colombia, Nov. 30, 2022 FN Media Group Presents USA News Group News Commentary...
PR Newswire
4days ago
Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement PR Newswire INDIANAPOLIS, Nov. 29, 2022 INDIANAPOLIS, Nov. 29, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its...
Zolmax
7days ago
Rafferty Asset Management LLC lessened its holdings in Eli Lilly and Company (NYSE:LLY Get Rating) by 23.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 19,932 shares of the companys stock after selling 5,977 shares during the quarter. Rafferty Asset Management ...
Zolmax
7days ago
Rafferty Asset Management LLC lessened its holdings in Eli Lilly and Company (NYSE:LLY Get Rating) by 23.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 19,932 shares of the companys stock after selling 5,977 shares during the quarter. Rafferty Asset Management ...
Guardian - Technology
14days ago
Furor over platforms verified profiles may have done some good, but challenges still plague the site after a mass worker exodusAgainst warnings that Twitter is on the verge of collapse, the social media platform hadnt died Saturday at least not yet. But things arent necessarily going well for new ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$374.76
$4.43
(1.2%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00